A new IARC live webinar on evidence in primary cancer prevention By Ogkologos - November 11, 2021 463 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer ESMO Welcomes Launch of Health Package Introducing EU Measures That Can Boost Innovation in Oncology and Help Prevent New Cancer Cases Adding Tafasitamab to Lenalidomide and Rituximab Prolongs PFS in Patients with Relapsed or Refractory Follicular Lymphoma MOST POPULAR EMA Recommends Extension of Indications for Daratumumab June 10, 2021 Dwayne Johnson Sends Special “Moana” Message To 3-Yr-Old Battling Cancer. November 21, 2019 FDA Grants Accelerated Approval to Lurbinectedin for Metastatic SCLC June 19, 2020 Characterisation of KRAS, Including KRAS G12C, Mutations in Gastrointestinal and Metastatic... July 2, 2021 Load more HOT NEWS Maintenance Olaparib in Elderly Patients With a Germline BRCA Mutation and... Sotorasib Shows Increase in PFS and a More Favourable Safety Compared... Five Questions With…Jim. Robust and Sustained Survival Benefit with Consolidation Durvalumab After Concurrent Chemoradiotherapy...
